{"frames":[{"target":{"name":"Craft","spans":[{"start":0,"end":1,"text":"Science"}]},"annotationSets":[{"rank":0,"score":11.691366466170551,"frameElements":[]}]},{"target":{"name":"Medical_specialties","spans":[{"start":2,"end":3,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.571156479647906,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":3,"text":"Science translational medicine"}]}]}]}],"tokens":["Science","translational","medicine","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":4,"end":5,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Predicting","spans":[{"start":6,"end":7,"text":"predicts"}]},"annotationSets":[{"rank":0,"score":37.43321790858824,"frameElements":[{"name":"Eventuality","spans":[{"start":7,"end":12,"text":"relapse in early breast cancer"}]},{"name":"Speaker","spans":[{"start":0,"end":6,"text":"Mutation tracking in circulating tumor DNA"}]}]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":9,"end":10,"text":"early"}]},"annotationSets":[{"rank":0,"score":30.19833461184307,"frameElements":[]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":10,"end":11,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.75015502282971,"frameElements":[{"name":"Body_part","spans":[{"start":10,"end":11,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":11,"end":12,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":35.29178407157971,"frameElements":[]}]}],"tokens":["Mutation","tracking","in","circulating","tumor","DNA","predicts","relapse","in","early","breast","cancer","."]}
{"frames":[{"target":{"name":"Observable_body_parts","spans":[{"start":4,"end":5,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.58576069629196,"frameElements":[{"name":"Body_part","spans":[{"start":4,"end":5,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":8,"end":9,"text":"high"}]},"annotationSets":[{"rank":0,"score":20.15995497414031,"frameElements":[{"name":"Value","spans":[{"start":8,"end":9,"text":"high"}]}]}]},{"target":{"name":"Run_risk","spans":[{"start":9,"end":10,"text":"risk"}]},"annotationSets":[{"rank":0,"score":55.668584282850894,"frameElements":[{"name":"Asset","spans":[{"start":8,"end":9,"text":"high"}]}]}]},{"target":{"name":"Grant_permission","spans":[{"start":13,"end":14,"text":"allow"}]},"annotationSets":[{"rank":0,"score":62.17982312746746,"frameElements":[{"name":"Grantor","spans":[{"start":0,"end":12,"text":"The identification of early-stage breast cancer patients at high risk of relapse"}]},{"name":"Action","spans":[{"start":14,"end":19,"text":"tailoring of adjuvant therapy approaches"}]}]}]},{"target":{"name":"Cure","spans":[{"start":17,"end":18,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":44.43086878230764,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":18,"end":19,"text":"approaches"}]},"annotationSets":[{"rank":0,"score":22.342892887638023,"frameElements":[{"name":"Means","spans":[{"start":18,"end":19,"text":"approaches"}]}]}]}],"tokens":["The","identification","of","early-stage","breast","cancer","patients","at","high","risk","of","relapse","would","allow","tailoring","of","adjuvant","therapy","approaches","."]}
{"frames":[{"target":{"name":"Assessing","spans":[{"start":1,"end":2,"text":"assessed"}]},"annotationSets":[{"rank":0,"score":106.81904657324878,"frameElements":[{"name":"Phenomenon","spans":[{"start":2,"end":28,"text":"whether analysis of circulating tumor DNA -LRB- ctDNA -RRB- in plasma can be used to monitor for minimal residual disease -LRB- MRD -RRB- in breast cancer"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":3,"end":4,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":48.042501822707756,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":6,"end":7,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Likelihood","spans":[{"start":13,"end":14,"text":"can"}]},"annotationSets":[{"rank":0,"score":29.715781607040558,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":3,"end":13,"text":"analysis of circulating tumor DNA -LRB- ctDNA -RRB- in plasma"}]}]}]},{"target":{"name":"Using","spans":[{"start":15,"end":16,"text":"used"}]},"annotationSets":[{"rank":0,"score":116.94334185149522,"frameElements":[{"name":"Instrument","spans":[{"start":3,"end":13,"text":"analysis of circulating tumor DNA -LRB- ctDNA -RRB- in plasma"}]},{"name":"Purpose","spans":[{"start":16,"end":28,"text":"to monitor for minimal residual disease -LRB- MRD -RRB- in breast cancer"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":17,"end":18,"text":"monitor"}]},"annotationSets":[{"rank":0,"score":48.286166796612825,"frameElements":[{"name":"Ground","spans":[{"start":18,"end":28,"text":"for minimal residual disease -LRB- MRD -RRB- in breast cancer"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":21,"end":22,"text":"disease"}]},"annotationSets":[{"rank":0,"score":34.09944928416083,"frameElements":[{"name":"Ailment","spans":[{"start":21,"end":22,"text":"disease"}]}]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":26,"end":27,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.870718457906875,"frameElements":[{"name":"Body_part","spans":[{"start":26,"end":27,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":27,"end":28,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":35.05253134472619,"frameElements":[]}]}],"tokens":["We","assessed","whether","analysis","of","circulating","tumor","DNA","-LRB-","ctDNA","-RRB-","in","plasma","can","be","used","to","monitor","for","minimal","residual","disease","-LRB-","MRD","-RRB-","in","breast","cancer","."]}
{"frames":[{"target":{"name":"Aggregate","spans":[{"start":3,"end":4,"text":"cohort"}]},"annotationSets":[{"rank":0,"score":26.07987135775793,"frameElements":[{"name":"Aggregate","spans":[{"start":3,"end":4,"text":"cohort"}]},{"name":"AggregateProperty","spans":[{"start":2,"end":3,"text":"prospective"}]},{"name":"Individuals","spans":[{"start":4,"end":13,"text":"of 55 early breast cancer patients receiving neoadjuvant chemotherapy"}]}]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":6,"end":7,"text":"early"}]},"annotationSets":[{"rank":0,"score":30.19833461184307,"frameElements":[]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":7,"end":8,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.47403963329994,"frameElements":[{"name":"Body_part","spans":[{"start":7,"end":8,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":8,"end":9,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Receiving","spans":[{"start":10,"end":11,"text":"receiving"}]},"annotationSets":[{"rank":0,"score":49.46673277277799,"frameElements":[{"name":"Recipient","spans":[{"start":9,"end":10,"text":"patients"}]},{"name":"Theme","spans":[{"start":11,"end":13,"text":"neoadjuvant chemotherapy"}]}]}]},{"target":{"name":"Activity_finish","spans":[{"start":20,"end":21,"text":"completion"}]},"annotationSets":[{"rank":0,"score":56.83590714438153,"frameElements":[{"name":"Activity","spans":[{"start":21,"end":25,"text":"of apparently curative treatment-either"}]}]}]},{"target":{"name":"Cure","spans":[{"start":23,"end":24,"text":"curative"}]},"annotationSets":[{"rank":0,"score":42.99998129646465,"frameElements":[]}]},{"target":{"name":"Sole_instance","spans":[{"start":27,"end":28,"text":"single"}]},"annotationSets":[{"rank":0,"score":5.8437888856555835,"frameElements":[]}]},{"target":{"name":"Measure_duration","spans":[{"start":29,"end":30,"text":"time"}]},"annotationSets":[{"rank":0,"score":16.977928822711213,"frameElements":[{"name":"Unit","spans":[{"start":29,"end":30,"text":"time"}]},{"name":"Count","spans":[{"start":28,"end":29,"text":"postsurgical"}]}]}]},{"target":{"name":"Locale","spans":[{"start":30,"end":31,"text":"point"}]},"annotationSets":[{"rank":0,"score":35.1559629355972,"frameElements":[{"name":"Locale","spans":[{"start":30,"end":31,"text":"point"}]},{"name":"Descriptor","spans":[{"start":28,"end":29,"text":"postsurgical"}]}]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":40,"end":41,"text":"high"}]},"annotationSets":[{"rank":0,"score":21.07151632058742,"frameElements":[{"name":"Item","spans":[{"start":41,"end":42,"text":"accuracy"}]},{"name":"Value","spans":[{"start":40,"end":41,"text":"high"}]}]}]},{"target":{"name":"Trust","spans":[{"start":41,"end":42,"text":"accuracy"}]},"annotationSets":[{"rank":0,"score":18.22283287309599,"frameElements":[{"name":"Information","spans":[{"start":40,"end":41,"text":"high"}]}]}]},{"target":{"name":"Statement","spans":[{"start":43,"end":44,"text":"hazard"}]},"annotationSets":[{"rank":0,"score":93.47827306415245,"frameElements":[]}]},{"target":{"name":"Certainty","spans":[{"start":48,"end":49,"text":"confidence"}]},"annotationSets":[{"rank":0,"score":32.0995657047318,"frameElements":[{"name":"Cognizer","spans":[{"start":47,"end":48,"text":"-LRB-"}]}]}]},{"target":{"name":"Frequency","spans":[{"start":49,"end":50,"text":"interval"}]},"annotationSets":[{"rank":0,"score":31.976395509413326,"frameElements":[]}]},{"target":{"name":"Certainty","spans":[{"start":63,"end":64,"text":"confidence"}]},"annotationSets":[{"rank":0,"score":32.12631053766796,"frameElements":[{"name":"Cognizer","spans":[{"start":62,"end":63,"text":"-LRB-"}]}]}]},{"target":{"name":"Frequency","spans":[{"start":64,"end":65,"text":"interval"}]},"annotationSets":[{"rank":0,"score":31.976395509413326,"frameElements":[]}]}],"tokens":["In","a","prospective","cohort","of","55","early","breast","cancer","patients","receiving","neoadjuvant","chemotherapy",",","detection","of","ctDNA","in","plasma","after","completion","of","apparently","curative","treatment-either","at","a","single","postsurgical","time","point","or","with","serial","follow-up","plasma","samples-predicted","metastatic","relapse","with","high","accuracy","-LSB-","hazard","ratio",",","25.1","-LRB-","confidence","interval",",","4.08","to","130.5",";","log-rank","P","<","0.0001","-RRB-","or","12.0","-LRB-","confidence","interval",",","3.36","to","43.07",";","log-rank","P","<","0.0001","-RRB-",",","respectively","-RSB-","."]}
{"frames":[{"target":{"name":"Change_position_on_a_scale","spans":[{"start":5,"end":6,"text":"increased"}]},"annotationSets":[{"rank":0,"score":108.04605391453643,"frameElements":[{"name":"Attribute","spans":[{"start":6,"end":12,"text":"sensitivity for the prediction of relapse"}]}]}]},{"target":{"name":"Health_response","spans":[{"start":6,"end":7,"text":"sensitivity"}]},"annotationSets":[{"rank":0,"score":17.430230164971572,"frameElements":[]}]},{"target":{"name":"Expectation","spans":[{"start":9,"end":10,"text":"prediction"}]},"annotationSets":[{"rank":0,"score":25.43422902142755,"frameElements":[]}]},{"target":{"name":"First_rank","spans":[{"start":16,"end":17,"text":"lead"}]},"annotationSets":[{"rank":0,"score":13.319544174384589,"frameElements":[{"name":"Item","spans":[{"start":17,"end":18,"text":"time"}]}]}]},{"target":{"name":"Measure_duration","spans":[{"start":17,"end":18,"text":"time"}]},"annotationSets":[{"rank":0,"score":19.935488161735613,"frameElements":[{"name":"Unit","spans":[{"start":17,"end":18,"text":"time"}]},{"name":"Count","spans":[{"start":16,"end":17,"text":"lead"}]},{"name":"Process","spans":[{"start":18,"end":21,"text":"of 7.9 months"}]}]}]},{"target":{"name":"Calendric_unit","spans":[{"start":20,"end":21,"text":"months"}]},"annotationSets":[{"rank":0,"score":29.67354730896982,"frameElements":[{"name":"Count","spans":[{"start":19,"end":20,"text":"7.9"}]}]}]}],"tokens":["Mutation","tracking","in","serial","samples","increased","sensitivity","for","the","prediction","of","relapse",",","with","a","median","lead","time","of","7.9","months","over","clinical","relapse","."]}
{"frames":[{"target":{"name":"Increment","spans":[{"start":1,"end":2,"text":"further"}]},"annotationSets":[{"rank":0,"score":13.717567093101167,"frameElements":[]}]},{"target":{"name":"Reasoning","spans":[{"start":2,"end":3,"text":"demonstrated"}]},"annotationSets":[{"rank":0,"score":43.196734376097034,"frameElements":[{"name":"Content","spans":[{"start":3,"end":17,"text":"that targeted capture sequencing analysis of ctDNA could define the genetic events of MRD"}]},{"name":"Arguer","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":7,"end":8,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":46.64250779819638,"frameElements":[{"name":"Ground","spans":[{"start":8,"end":10,"text":"of ctDNA"}]}]}]},{"target":{"name":"Capability","spans":[{"start":10,"end":11,"text":"could"}]},"annotationSets":[{"rank":0,"score":40.618294039655595,"frameElements":[{"name":"Event","spans":[{"start":11,"end":12,"text":"define"}]},{"name":"Entity","spans":[{"start":6,"end":10,"text":"sequencing analysis of ctDNA"}]}]}]},{"target":{"name":"Communicate_categorization","spans":[{"start":11,"end":12,"text":"define"}]},"annotationSets":[{"rank":0,"score":40.484252418510025,"frameElements":[{"name":"Speaker","spans":[{"start":6,"end":10,"text":"sequencing analysis of ctDNA"}]},{"name":"Item","spans":[{"start":12,"end":15,"text":"the genetic events"}]}]}]},{"target":{"name":"Event","spans":[{"start":14,"end":15,"text":"events"}]},"annotationSets":[{"rank":0,"score":28.653100952697173,"frameElements":[{"name":"Event","spans":[{"start":13,"end":14,"text":"genetic"}]}]}]},{"target":{"name":"Expectation","spans":[{"start":22,"end":23,"text":"predicted"}]},"annotationSets":[{"rank":0,"score":31.838181173803818,"frameElements":[{"name":"Phenomenon","spans":[{"start":23,"end":39,"text":"the genetic events of the subsequent metastatic relapse more accurately than sequencing of the primary cancer"}]}]}]},{"target":{"name":"Event","spans":[{"start":25,"end":26,"text":"events"}]},"annotationSets":[{"rank":0,"score":29.461291024345552,"frameElements":[{"name":"Event","spans":[{"start":24,"end":25,"text":"genetic"}]}]}]},{"target":{"name":"Relative_time","spans":[{"start":28,"end":29,"text":"subsequent"}]},"annotationSets":[{"rank":0,"score":18.54238681386274,"frameElements":[]}]},{"target":{"name":"Increment","spans":[{"start":31,"end":32,"text":"more"}]},"annotationSets":[{"rank":0,"score":18.9860274284321,"frameElements":[{"name":"Class","spans":[{"start":32,"end":39,"text":"accurately than sequencing of the primary cancer"}]}]}]},{"target":{"name":"Locale_by_use","spans":[{"start":32,"end":33,"text":"accurately"}]},"annotationSets":[{"rank":0,"score":34.182675712883075,"frameElements":[{"name":"Locale","spans":[{"start":32,"end":33,"text":"accurately"}]}]}]},{"target":{"name":"First_rank","spans":[{"start":37,"end":38,"text":"primary"}]},"annotationSets":[{"rank":0,"score":13.741922140763439,"frameElements":[{"name":"Item","spans":[{"start":38,"end":39,"text":"cancer"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":38,"end":39,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":34.98607510754551,"frameElements":[]}]}],"tokens":["We","further","demonstrated","that","targeted","capture","sequencing","analysis","of","ctDNA","could","define","the","genetic","events","of","MRD",",","and","that","MRD","sequencing","predicted","the","genetic","events","of","the","subsequent","metastatic","relapse","more","accurately","than","sequencing","of","the","primary","cancer","."]}
{"frames":[{"target":{"name":"Capability","spans":[{"start":2,"end":3,"text":"can"}]},"annotationSets":[{"rank":0,"score":42.67183439745789,"frameElements":[{"name":"Event","spans":[{"start":3,"end":4,"text":"therefore"}]},{"name":"Entity","spans":[{"start":0,"end":2,"text":"Mutation tracking"}]}]}]},{"target":{"name":"Verification","spans":[{"start":4,"end":5,"text":"identify"}]},"annotationSets":[{"rank":0,"score":65.65206239122286,"frameElements":[{"name":"Unconfirmed_content","spans":[{"start":0,"end":2,"text":"Mutation tracking"}]}]}]},{"target":{"name":"Temporal_subregion","spans":[{"start":5,"end":6,"text":"early"}]},"annotationSets":[{"rank":0,"score":16.82408487369733,"frameElements":[{"name":"Sub_part","spans":[{"start":5,"end":6,"text":"early"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":7,"end":8,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":10,"end":11,"text":"high"}]},"annotationSets":[{"rank":0,"score":20.15995497414031,"frameElements":[{"name":"Value","spans":[{"start":10,"end":11,"text":"high"}]}]}]},{"target":{"name":"Run_risk","spans":[{"start":11,"end":12,"text":"risk"}]},"annotationSets":[{"rank":0,"score":55.668584282850894,"frameElements":[{"name":"Asset","spans":[{"start":10,"end":11,"text":"high"}]}]}]}],"tokens":["Mutation","tracking","can","therefore","identify","early","breast","cancer","patients","at","high","risk","of","relapse","."]}
{"frames":[{"target":{"name":"Relative_time","spans":[{"start":0,"end":1,"text":"Subsequent"}]},"annotationSets":[{"rank":0,"score":18.54238681386274,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":2,"end":3,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Capability","spans":[{"start":4,"end":5,"text":"could"}]},"annotationSets":[{"rank":0,"score":41.475857926666876,"frameElements":[{"name":"Event","spans":[{"start":0,"end":4,"text":"Subsequent adjuvant therapeutic interventions"}]},{"name":"Entity","spans":[{"start":8,"end":11,"text":"the genetic events"}]}]}]},{"target":{"name":"Event","spans":[{"start":10,"end":11,"text":"events"}]},"annotationSets":[{"rank":0,"score":34.016529745875694,"frameElements":[{"name":"Event","spans":[{"start":8,"end":11,"text":"the genetic events"}]}]}]},{"target":{"name":"Presence","spans":[{"start":11,"end":12,"text":"present"}]},"annotationSets":[{"rank":0,"score":10.963063407799677,"frameElements":[{"name":"Location","spans":[{"start":12,"end":31,"text":"in the MRD , a therapeutic approach that could in part combat the challenge posed by intratumor genetic heterogeneity"}]},{"name":"Entity","spans":[{"start":8,"end":11,"text":"the genetic events"}]}]}]},{"target":{"name":"Cure","spans":[{"start":17,"end":18,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":18,"end":19,"text":"approach"}]},"annotationSets":[{"rank":0,"score":21.003722929743,"frameElements":[{"name":"Means","spans":[{"start":18,"end":19,"text":"approach"}]}]}]},{"target":{"name":"Capability","spans":[{"start":20,"end":21,"text":"could"}]},"annotationSets":[{"rank":0,"score":40.95376452286315,"frameElements":[{"name":"Event","spans":[{"start":21,"end":23,"text":"in part"}]},{"name":"Entity","spans":[{"start":16,"end":19,"text":"a therapeutic approach"}]}]}]},{"target":{"name":"Part_whole","spans":[{"start":22,"end":23,"text":"part"}]},"annotationSets":[{"rank":0,"score":17.07838711883231,"frameElements":[{"name":"Part","spans":[{"start":22,"end":23,"text":"part"}]},{"name":"Whole","spans":[{"start":24,"end":31,"text":"the challenge posed by intratumor genetic heterogeneity"}]}]}]},{"target":{"name":"Hostile_encounter","spans":[{"start":23,"end":24,"text":"combat"}]},"annotationSets":[{"rank":0,"score":78.41127388538311,"frameElements":[{"name":"Side_1","spans":[{"start":21,"end":23,"text":"in part"}]},{"name":"Side_2","spans":[{"start":24,"end":31,"text":"the challenge posed by intratumor genetic heterogeneity"}]}]}]},{"target":{"name":"Difficulty","spans":[{"start":25,"end":26,"text":"challenge"}]},"annotationSets":[{"rank":0,"score":33.537074016969456,"frameElements":[{"name":"Activity","spans":[{"start":25,"end":26,"text":"challenge"}]}]}]},{"target":{"name":"Causation","spans":[{"start":26,"end":27,"text":"posed"}]},"annotationSets":[{"rank":0,"score":61.161703434520085,"frameElements":[{"name":"Cause","spans":[{"start":24,"end":26,"text":"the challenge"}]},{"name":"Effect","spans":[{"start":27,"end":31,"text":"by intratumor genetic heterogeneity"}]}]}]},{"target":{"name":"Weapon","spans":[{"start":30,"end":31,"text":"heterogeneity"}]},"annotationSets":[{"rank":0,"score":46.58094041218807,"frameElements":[{"name":"Weapon","spans":[{"start":30,"end":31,"text":"heterogeneity"}]}]}]}],"tokens":["Subsequent","adjuvant","therapeutic","interventions","could","be","tailored","to","the","genetic","events","present","in","the","MRD",",","a","therapeutic","approach","that","could","in","part","combat","the","challenge","posed","by","intratumor","genetic","heterogeneity","."]}
